Ligand Pharma (LGND) stock gains as Citi rates the company a Buy, highlighting its underappreciated value despite its strong ...
The agency’s sweeping rollout and staff challenge underscore rising momentum behind agentic AI: advanced, multiagent systems ...
Pfizer (PFE) is reiterated as a Buy, supported by the world's largest drug pipeline and trading below intrinsic value, ...
RSV treatments may be in trouble; Lilly’s dealmaker outlines plans for GLP-1 money; Pfizer’s latest obesity pill bid.
Recursion Pharma , which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in patients with a rare ...
Yao Pharma's deal with the US pharmaceutical giant underscores China's growing role in global biotech licensing US ...
Zacks Investment Research on MSN
Pharma ETFs to gain from landmark UK-US zero-tariff deal
At the onset of this month, the UK and U.S. governments signed a landmark pharmaceuticals trade deal aimed at rebalancing transatlantic commerce and securing access to innovative medicines. The core ...
We used Finviz to compile a list of the best pharma stocks and selected the top 11 with the highest number of hedge fund ...
America wants to reduce its reliance on Chinese supply chains, since it remains in a trade war that is only temporarily on hold. The government frets already about China’s chokehold on active drug ...
What China is accomplishing in R&D “has implications for everyone playing in the R&D or innovation world,” McKinsey’s ...
The FDA is investigating a safety signal from Takeda’s rare disease med Adzynma. Otsuka won a first-in-class FDA approval to ...
Pharma Equity Group executes on the Company's new strategy: Enters into Letter of Intent to acquire the MedTech company Otiom A/S Company Announcement no. 15 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback